Forest Labs (FRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Forest Labs (FRX)

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: radman33 who wrote ()	6/8/2000 3:19:00 PM
From: radman33	of 9

Does anyone else out there have any useful information on FRX? Marketing protection for Celexa expires in 2003 which will obviously have a negative impact on the stock as well as Prozac coming off patent protection. However, they should still have 2-3 years of outstanding earnings growth with Celexa as the primary earnings driver. FRX is trading at 66x 1999 earnings but only 44x 2000E; expensive compared to MRK/JNJ/LLY/etc, but in line with WLA/PFE/PHA which are all growing at similar rates. Jay

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext